Skip to Main Content

Author Details

Roderick C N van den Bergh
St. Antonius Hospital
2007
161
40
PMIDPaper TitleJournal TitlePublished Year
37355358European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter Study.Eur Urol2024
37748970Reply to Badar M. Mian. Prostate Biopsy: Hyperbole and Misrepresentation Versus Scientific Evidence and Equipoise. Eur Urol. 2024;85:99-100.Eur Urol2024
37945451The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies.Eur Urol2024
37414703Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data.Eur Urol2024
37296065Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT).Eur Urol Oncol2024
34305038Intermediate-risk Prostate Cancer-A Sheep in Wolf's Clothing?Eur Urol Oncol2023
37755520The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS⿿⿥⿿3 lesions.World J Urol2023
37845121Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study.Eur Urol Oncol2023
37835494Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital.Cancers (Basel)2023
37643855TripleAiM1: a nationwide registry of de novo metastatic hormone-sensitive prostate cancer with prospective quality-of-life assessment.BMJ Open2023
37530704The role of nuclear medicine tracers for prostate cancer surgery: from preoperative to intraoperative setting.Curr Opin Urol2023
37455399Immunohistochemical and histopathological validation of <sup>18</sup> F-PSMA-1007 PET/CT for intraprostatic cancerous lesions.Prostate2023
37117107Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.Eur Urol2023
37052482Reply by Authors.J Urol2023
37052480Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma.J Urol2023
36746729Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.Eur Urol Focus2023
36874601Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting.Eur Urol Open Sci2023
36609130The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management.Clin Genitourin Cancer2023
36804735Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review.Eur Urol Oncol2023
36280445Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.Eur Urol Oncol2023
36284192Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis.Prostate Cancer Prostatic Dis2023
36282548Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE criteria: does local treatment alone still have a place in the era of intensified systemic therapies?Minerva Urol Nephrol2023
34147405Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review.Eur Urol Focus2022
35465985Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis.Eur Urol2022
35393568The current role of MRI for guiding active surveillance in prostate cancer.Nat Rev Urol2022
35848342Comment on: "The impact of age on pathological insignificant prostate cancer rates in contemporary robot-assisted prostatectomy patients despite active surveillance eligibility".Minerva Urol Nephrol2022
36046616Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?Eur Urol Open Sci2022
36310760Superfast Magnetic Resonance Imaging-based Diagnostic Pathway for Prostate Cancer.Eur Urol Open Sci2022
36303075Quality of early prostate cancer follow-up care from the patients' perspective.Support Care Cancer2022
36328090Trends and variation in the use of radiotherapy in non-metastatic prostate cancer: A 12-year nationwide overview from the Netherlands.Radiother Oncol2022
35985901Prostate Cancer Detection Percentages of Repeat Biopsy in Patients with Positive Multiparametric Magnetic Resonance Imaging (Prostate Imaging Reporting and Data System/Likert 3-5) and Negative Initial Biopsy. A Mini Systematic Review.Eur Urol2022
35918262Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison.Clin Genitourin Cancer2022
36344738A side-specific nomogram for extraprostatic extension may reduce the positive surgical margin rate in radical prostatectomy.World J Urol2022
36082555The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study.J Urol2022
33926838Long-term Outcomes of Focal Cryotherapy for Low- to Intermediate-risk Prostate Cancer: Results and Matched Pair Analysis with Active Surveillance.Eur Urol Focus2022
35317972Predictors of Unfavorable Pathology in Patients with Incidental (pT1a-T1b) Prostate Cancer.Eur Urol Focus2022
35074282Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Is Associated with Improved Oncological Outcome in Men Treated with Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer.Eur Urol Oncol2022
34980492Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.Eur Urol2022
35064800Arterio-ureteral fistula: a nationwide cross-sectional questionnaire analysis.World J Urol2022
34933831Clinical Trial Protocol for PSMA-SELECT: A Dutch National Randomised Study of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as a Triage Tool for Pelvic Lymph Node Dissection in Patients Undergoing Radical Prostatectomy.Eur Urol Focus2022
34555933Arterio-Ureteral Fistula: Systematic Review of 445 Patients.J Urol2022
34547922An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer.J Urol2022
34812201Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidence.Curr Opin Urol2022
34399996Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups.Eur Urol2022
33967010Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.Eur Urol Focus2022
31570269Adherence to Active Surveillance Protocols: Well Meant but Overconcerned?Eur Urol Oncol2021
35475150Selection of patients for nerve sparing surgery in robot-assisted radical prostatectomy.BJUI Compass2021
35008310Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future Perspectives.Cancers (Basel)2021
34549198TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate-Referee.Eur Urol Open Sci2021
34729226Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU - YAU Prostate Cancer Working Group multi-institutional study.Cent European J Urol2021
  • 1 - 50 of 161

Recommended Authors

Giovanni Motterle
Mayo Clinic
Career Start Year 2017
Number of shared co-authors 7
Neil Mendhiratta
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 0
Adam B Weiner
Northwestern University Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 3
R Jeffrey Karnes
Mayo Clinic
Career Start Year 2013
Number of shared co-authors 11
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 4
Devin N Patel
university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 2
Jeffrey J Tosoian
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 6
Michael A Liss
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 2
Marco Randazzo
Winterthur Cantonal Hospital
Career Start Year 2005
Number of shared co-authors 4
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 3
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 11
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Career Start Year 2004
Number of shared co-authors 15
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 10
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 7
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 2
Robert Jeffrey Karnes
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 18
Vincent J Gnanapragasam
University of Cambridge
Career Start Year 1999
Number of shared co-authors 7
Jim C Hu
Weill Cornell Medical Center
Career Start Year 1998
Number of shared co-authors 13
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 5
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 17
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 9
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 19
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 8
Byung Ha Chung
Yonsei University College of Medicine and Gangnam Severance Hospital
Career Start Year 1992
Number of shared co-authors 6
Neil E Fleshner
University of Toronto
Career Start Year 1989
Number of shared co-authors 18
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 16
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 11
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 7
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 21
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Career Start Year 1956
Number of shared co-authors 10

Collaborators

Giorgio Gandaglia
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Co-authored papers 49
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Co-authored papers 38
Monique J Roobol
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 33
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Co-authored papers 32
Piet Ost
Ghent University, GZA Ziekenhuizen
Co-authored papers 21
Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
Co-authored papers 21
Philip Cornford
Liverpool University Hospitals
Co-authored papers 20
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 20
Ewout W Steyerberg
Leiden University Medical Center
Co-authored papers 11
Geert J L H van Leenders
Erasmus MC Cancer Institute, University Medical Center
Co-authored papers 9
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers 9
Inge M van Oort
Radboud University Medical Center
Co-authored papers 7
Hendrik Van Poppel
University Hospitals Leuven
Co-authored papers 5
Michel Bolla
universite Grenoble-Alpes (UGA)
Co-authored papers 5
Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Co-authored papers 5
Riccardo Campi
Careggi University Hospital
Co-authored papers 3
James N'Dow
University of Aberdeen
Co-authored papers 3
Anthony J Costello
Royal Melbourne Hospital
Co-authored papers 3
Mark Frydenberg
Monash University
Co-authored papers 2
Anders Bjartell
Skane University Hospital, Lund University
Co-authored papers 2
Freddie C Hamdy
University of Oxford
Co-authored papers 2
Niven Mehra
Radboud university medical center
Co-authored papers 2
Asieh Golozar
Northeastern University
Co-authored papers 1
Heidi V N K??sters-Vandevelde
Canisius Wilhelmina Hospital
Co-authored papers 1
Tim Hulsen
Department of Hospital Services & Informatics
Co-authored papers 1
Katja K H Aben
Co-authored papers 1
Fred Saad
University of Montreal Health Center
Co-authored papers 1
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Co-authored papers 1
Guido Jenster
Erasmus University Medical Center
Co-authored papers 1
Gert De Meerleer
University Hospitals Leuven
Co-authored papers 1
Release 1.2